Development of animal recombinant DNA vaccine and its efficacy in foxes.

Animals; Female; Foxes/microbiology; Immunization Schedule; Male; Rabies/prevention & control/veterinary; Rabies Vaccines/administration & dosage; Rabies virus; Vaccination/methods/veterinary; Vaccines/administration & dosage; Vaccines, Attenuated/administration & dosage; Vaccines, Synthetic/administration & dosage; Vaccinia virus; Viral Fusion Proteins

Abstract :

[en] Rabies is prevalent in most parts of the world. An extensive reservoir of the disease is present in the population of wild animals. The fox in particular is a major vector of the disease in North America and Europe. Although attempts to control rabies by vaccination of wild carnivores with attenuated rabies virus have met with some success, this approach remains controversial. The potential of a recombinant vaccinia virus expressing the rabies glycoprotein for the protection of foxes against rabies was examined. Both the parental (wild-type) and recombinant viruses were found to be innocuous to foxes. Inoculation of live recombinant virus via the subcutaneous, intradermal, or oral routes uniformly elicited high titers of neutralizing antibodies, and animals that received 10(8) plaque-forming units of the recombinant virus in bait resisted severe challenge with live rabies virus.

Disciplines :

Veterinary medicine & animal health

Author, co-author :

Kieny, M. P.

Blancou, J.

Lathe, R.

Pastoret, Paul-Pierre ; Université de Liège - Bruxelles > Médecine vétérinaire

Soulebot, J. P.

Desmettre, P.

Lecocq, J. P.

Language :

English

Title :

Development of animal recombinant DNA vaccine and its efficacy in foxes.

Publication date :

1988

Journal title :

Reviews of Infectious Diseases

ISSN :

0162-0886

Publisher :

University of Chicago Press, United States - Illinois

Volume :

10 Suppl 4

Pages :

S799-802

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 01 June 2019

Statistics

Number of views

67 (1 by ULiège)

Number of downloads

131 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Steck F. Rabies in wildlife. Symposium of the Zoological Society of London 1982;50:57-75.
Debbie JG. Rabies control in wildlife. In: Veterinary learning systems. Princeton. Reports on rabies. 1983;23-7.
Andral L, Blancou J. La rage. Nouveaux developpements enmatiere de vaccination. Rev Sci Tech Off Int Epiz 1982; 1:927-59.
Toma B, Andral L. Epidemiology of fox rabies. Adv Virus Res 1977;21:1-36.
Anderson RM, Jackson HC, May RM, Smith AM. Population dynamics of fox rabies in Europe. Nature 1981; 289:765-71.
Baer GM, Abelseth MK, Debbie JG. Oral vaccination of foxes against rabies. Am J Epidemiol 1971;93:487-90.
Mayr A, Kraft H, Jaeger O, Haacke H. Oral Immunisierung von Fiichsen gegen Tollwut. Zentralbl Veterinarmed [B] 1972;19:615-25.
Blancou J. Prophylaxie medicale de la rage chez le renard. Rev Med Vet 1979;155:733-41.
Kappeler A, Wandeler AI, Capt S. Geographical barriers to wildlife rabies spread: The concept and its application in oral immunization of foxes against rabies. Revue Ecologie (Terre Vie) 1985;40:267.
Schneider LG, Cox JH, Muller WW. Field trials of oral immunization of wildlife animals against rabies in the Federal Republic of Germany: A mid-course assessment. Revue Ecologie (Terre Vie) 1985;40:265-6.
Drillien R, Tripier F, Koehren F, Kirn A. A temperature-sensitive mutant of vaccinia virus defective in an early stage of morphogenesis. Virology 1977;79:369-80.
Blancou J, Aubert MFA, Andral L, Artois M. Rage experimentale du renard roux (Vulpes vulpes) 1. Sensibilite selon la voie d’infection et la dose infectante. Revue Medecine Veterinaire 1979;130:1001-15.
Kaplan MM, Koprowski H. Laboratory techniques in rabies. 3rd ed. Geneva: WHO, 1974.
Behbehani AM. The smallpox story: Life and death of an old disease. Microbiol Rev 1983;47:455-509.
Panicali D, Davis SW, Weinberg RL, Pauletti E. Construction of live vaccines by using genetically engineered poxviruses: Biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin. Proc Natl Acad Sci USA 1983;80:5364-8.
Smith GL, Mackett M, Moss B. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 1983;302:490-5.
Smith GL, Mackett M, Moss B. Recombinant vaccinia viruses as new live vaccines. Biotechnology and Genetic Engineering Reviews 1984;22:383-407.
Wunner WH, Dietzschold B, Curtis PJ, Wiktor TJ. Rabies subunit vaccines. J Gen Virol 1983;64:1649-56.
Kieny MP, Desmettre P, Soulebot JP, Lathe R. Rabies vac-cines: Traditional and novel approaches. Progress in Veterinary Microbiology and Immunology 1986;3.
Kieny MP, Lathe R, Drillien R, Spehner D, Skory S, Schmitt D, Wiktor T, Koprowski H, Lecocq JP. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 1984;312:163-6.
Wiktor TJ, MacFarlan RI, Reagan KJ, Dietzschold B, Cur-tis PJ, Wunner WH, Kieny M-P, Lathe R, Lecocq J-P, Mackett M, Moss B, Koprowski H. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci USA 1984;81:7194-8.
Lathe R, Kieny MP, Lecocq JP, Drillien R, Wiktor T, Ko-prowski H. Immunization against rabies using a vaccinia-rabies recombinant virus expressing the surface glycoprotein. In: Lerner RA, Chanock RM, Brown F, eds. Vaccines 85. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1985:157-62.
Dubreuil M, Andral L, Aubert MFA, Blancou J. The oral vaccination of foxes against rabies. An experimental study. Ann Rech Vet 1979;10:9-21.
Blancou J, Kieny MP, Lathe R, Lecocq JP, Pastoret PP, Soule-bot JP, Desmettre P. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature 1986;322:373-5.
Blancou J, Andral L, Aubert MFA, Barrat MJ, Cain E, Selve M. Vaccination du renard contre la rage par voie orale. Bulletin de L’Academie Veterinaires de France 1982; 55:351-9.
World Health Organization. Requirements for biological sub-stances. WHO Tech Rep Ser 1966;323.
Wiktor TJ, MacFarlan RI, Dietzschold B, Rupprecht C, Wun-ner WH. Immunogenic properties of vaccinia recombinant virus expressing the rabies glycoprotein. Ann Inst Pasteur Virol 1985;136E:405-12.